Triana Bio

Triana Biomedicines develops a molecular glue platform to degrade disease-causing proteins, targeting difficult-to-drug therapeutic areas.
Domain
Healthcare
Status
Current Private Investment
Stage of Initial Investment
NewCo
Initial Investment Year
2020
Triana Portco Hover Image